Dr. Jaime O. Henriquez, MD

Dr. Henriquez practices at Pacific Orthopaedic Medical Group in Arcadia, California.

Dr. Henriquez's NPI, 1922058718, was assigned on May 11, 2006. Dr. Henriquez graduated from Keck School of Medicine of USC in 1999. Dr. Henriquez holds California license A79202.

Dr. Henriquez's primary practice is Pacific Orthopaedic Medical Group, at 289 W Huntington Dr, Arcadia, CA 91007 in Los Angeles County. The practice phone is (626) 282-1600.

Dr. Henriquez's primary practice is Pacific Orthopaedic Medical Group in Arcadia, California. Dr. Henriquez is also affiliated with USC Arcadia Hospital. The medical group on file is Foothill Cardiology Medical Group. Dmand AI also links Dr. Henriquez to 2 more hospitals, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henriquez practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Henriquez's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Henriquez is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Henriquez's licenses on file in 2 states: California and New York.

Dmand AI lists angioplasty, cardiac catheterization and varicose vein treatment among the conditions Dr. Henriquez treats.

CMS data shows 4,518 Medicare services from Dr. Henriquez across 28 procedure codes in 2024, for 789 Medicare patients. Medicare paid $447,558 for them.

CMS counts 789 Medicare patients who saw Dr. Henriquez in 2024. The largest group is 75 to 84, with 345 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henriquez's median patient age at 76, with 46% women.

In 2024, Dr. Henriquez wrote 7,073 Medicare Part D claims for 1,061 patients. 84% of them were for generic drugs. CMS names the drug for 6,833 of them, across 38 drugs with 11 or more claims each, at $1,461,188 in total drug cost. In 2023, CMS named 6,921 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Henriquez for performance year 2024, reported as part of a group. Dr. Henriquez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Henriquez as offering telehealth. CMS counts 32 procedures of coronary angioplasty and stenting by Dr. Henriquez, more than 68% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Henriquez. Dr. Henriquez's most frequent co-authors are Ala'Eldin Ahmed Ababneh, MD, Olakunle O. Akinboboye, MD, MPH and Shilpi Epstein, MD.

CMS Open Payments shows 801 general payments to Dr. Henriquez from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbott Laboratories paid the most, $3,321.

Dr. Henriquez graduated from Keck School of Medicine of USC in 1999.

Dr. Henriquez is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.